等待开盘 08-29 09:30:00 美东时间
-0.070
-0.37%
ZimVie (NASDAQ:ZIMV) is preparing to release its quarterly earnings on Wednesda...
07-30 04:02
ZimVie Inc. announced it will report second quarter 2025 financial results and file its 10-Q on July 30, 2025. The company also revealed it will be acquired by ARCHIMED for $19.00 per share, with the transaction expected to close by year-end 2025. Upon completion, ZimVie will become a private company and its shares will no longer trade on NASDAQ. The company is withdrawing its fiscal 2025 guidance.
07-25 12:00
ZimVie Inc. and Osstem Implant Co., Ltd. have formed a strategic partnership to expand ZimVie's presence in the growing Chinese dental implant market. Osstem, a leading implant provider in China with a strong distribution network, will exclusively distribute ZimVie's implant systems, enhancing product access for customers. The collaboration leverages Osstem's established market presence and ZimVie's innovative implant solutions, aiming to increas...
07-23 20:05
今日重点评级关注:瑞杰金融:维持Antero Resources Corp."强烈买入"评级,目标价从57美元升至58美元;美银证券:维持和黄医药"买入"评级,目标价从27美元升至28美元
07-23 09:42
ZIMV飙涨超120%,公司获高额溢价收购;散户持续爆炒,“Meme股”OpenDoor续涨超42%;英伟达合作商纳微半导体大涨超24%>>
07-22 19:50
NEW YORK, July 21, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
07-22 00:44
ZimVie stock rallied on Monday after it announced an acquisition deal with ARCH...
07-21 21:23
ZimVie Inc ( ($ZIMV) ) has issued an announcement. On July 21, 2025, ZimVie Inc...
07-21 20:48
ZimVie Inc. ("ZimVie") (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of
07-21 20:04
ZimVie Inc., a global leader in the dental implant market, announced its definitive agreement to be acquired by ARCHIMED, an investment firm focused on healthcare, for $19.00 per share, totaling approximately $730 million. The transaction, which represents a 99% premium over ZimVie’s 90-day VWAP, is expected to close by year-end 2025, subject to shareholder and regulatory approvals. ZimVie’s board has unanimously approved the deal, and the compan...
07-21 12:00